Spanish Red Biotech Pipeline
< Back
Diagnostics and Personalized Medicine
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Diagnostics and Personalized Medicine
FUND. PROGRESO Y SALUD
FIBICO-19012 Use of splicing factors as therapeutic targets in prostate cancer.
Type:
Diagnostic
Therapeutic area:
Cancer
Indication:
Use of splicing factors as therapeutic targets in prostate cancer.
Phase:
1
R+D
Studies location: